GeneDx Holdings (WGS) Preferred Stock Liabilities (2020 - 2021)
GeneDx Holdings (WGS) posted quarterly Preferred Stock Liabilities of $334.4 million for Q2 2021, up 54.04% year-over-year from $217.1 million in Q2 2020, and little changed quarter-over-quarter from $334.4 million in Q1 2021.
GeneDx Holdings (WGS) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
GeneDx Holdings (WGS) has reported Preferred Stock Liabilities for 2 consecutive years, with $334.4 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Preferred Stock Liabilities rose 54.04% year-over-year to $334.4 million; the TTM figure through Jun 2021 stood at $334.4 million (up 54.04% YoY), while the FY2020 annual figure was $334.4 million, up 54.04% from the prior year.
- Preferred Stock Liabilities held at $334.4 million in Q2 2021 per WGS's latest filing, from $334.4 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $334.4 million in Q3 2020 and bottomed at $217.1 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 334.44 Mn |
| Mar 31, 2021 | 334.44 Mn |
| Dec 31, 2020 | 334.44 Mn |
| Sep 30, 2020 | 334.44 Mn |
| Jun 30, 2020 | 217.12 Mn |